Chronic endothelium-dependent regulation of arterial blood pressure by atrial natriuretic peptide: role of nitric oxide and endothelin-1

Endocrinology

Volumn 150, Issue 5, 2009, Pages 2382-2387

  Sabrane, Karim ^a,b   Kruse, Markus N ^b   Gazinski, Alexandra ^a   Kuhn, Michaela ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GUANYLATE CYCLASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ATRIAL NATRIURETIC FACTOR RECEPTOR; CELL RECEPTOR; NATRIURETIC PEPTIDE RECEPTOR A; NOS3 PROTEIN, MOUSE; SOLUBLE GUANYLYL CYCLASE; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; CAROTID ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; HYPERTENSION; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; TISSUE LEVEL; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; ANTIBODY SPECIFICITY; ARTERY; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; ARTERIES; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GUANYLATE CYCLASE; MICE; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SPECIFICITY; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; VASODILATION; VASODILATOR AGENTS;

EID: 66449113490     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1360     Document Type: Article

References (30)

1. Drewett JG, Garbers DL 1994 The family of guanylyl cyclase receptors and their ligands. Endocr Rev 15:135-162
2. Kuhn M 2003 Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ Res 93: 700-709
3. Moncada S, Higgs A 1993 The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012
4. Costa MD, Bosc LV, Majowicz MP, Vidal NA, Balaszczuk AM, Arranz CT 2000 Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats. Hypertension 35:1119-1123
5. Elesgaray R, Caniffi C, Ierace DR, Jaime MF, Fellet A, Arranz C, Costa MA 2008 Signaling cascade that mediates endothelial nitric oxide synthase activation induced by atrial natriuretic peptide. Regul Pept 151:130-134
6. Stingo AJ, Clavell AL, Heublein DM, Wei CM, Pittelkow MR, Burnett Jr JC 1992 Presence of C-type natriure ticpeptidein cultured humanendo the lialcells and plasma. Am J Physiol 263(4 Pt 2):H1318-H1321
7. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S 1990 Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732
8. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T1990 Cloning of ac DNA encodinganon-is opeptide-selectives ub type of the endothel in receptor. Nature 348:732-735
9. Gray GA, Webb DJ 1996 The endothelin system and its potential as a therapeutic target in cardiovascular disease. Pharmacol Ther 72:109 -148
10. Han B, Hasin Y 2003 Cardiovascular effects of natriuretic peptides and their interrelation with endothelin-1. Cardiovasc Drugs Ther 17:41-52
11. Hu RM, Levin ER, Pedram A, Frank HJ 1992 Atrialnat riureticpep tideinhibits the production and secretion of endothelin from cultured endothelial cells. Mediation through the C receptor. J Biol Chem 267:17384-17389
12. Wada A, Tsutamato T, Maeda Y, Kanamori T, Matsuda Y, Kinoshita M 1996 Endogenous atrial natriuretic peptide inhibits endothelin-1 secretion in dog with severecongestiveheartfailure. Am J Physiol 270(5 Pt2):H1819-H1824
13. John SW, Veress AT, Honrath U, Chong CK, Peng L, Smithies O, Sonnenberg H 1996 Blood pressure and fluid-electrolyte balance in mice with reduced or absent ANP. Am J Physiol 271(1 Pt 2):R109-R114
14. Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Beuve A 1995 Salt-resistant hypertension in mice lacking the guanylyl cycla- se-A receptor for atrial natriuretic peptide. Nature 378:65-68
15. Sabrane K, Kruse MN, Fabritz L, Zetsche B, Mitko D, Skryabin BV, Zwiener M, Baba HA, Yanagisawa M, Kuhn M 2005 Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic pep-tide. J Clin Invest 115:1666-1674
16. Schreier B, Bcirner S, Volker K, Gambaryan S, Schafer SC, Kuhlencordt P, Gassner B, Kuhn M 2008 The heart communicates with the endothelium through the guanylyl cyclase-A receptor: acute handling of intravascular volume in response to volume expansion. Endocrinology 149:4193-4199
17. Mulvany MJ, Aalkjaer C 1990 Structure and function ofsmallarteries. Physiol Rev 70:921-961
18. Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, Zetsche B, Hammer RE, Herz J, Kuhn M 2002 Smooth muscle-selective deletion of gua- nylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci USA 99:7142-7147
19. Melo LG, Veress AT, Ackermann U, Sonnenberg H 1998 Chronic regulation of arterial blood pressure by ANP: role of endogenous vasoactive endothelial factors. Am J Physiol 275(5 Pt 2):H1826-H1833
20. Ihara M, Ishikawa K, Fukuroda T, Saeki T, Funabashi K, Fukami T, Suda H, Yano M 1992 In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor. J Cardiovasc Pharmacol 20(Suppl 12):S11-S14
21. Brandes RP, Kim D, Schmitz-Winnenthal FH, Amidi M, Godecke A, Miilsch A, Busse R 2000 Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Hypertension 35:231-236
22. Hocher B, Zart R, Schwarz A, Vogt V, Braun C, Thone-Reineke C, Braun N, Neumayer HH, Koppenhagen K, Bauer C, Rohmeiss P 1998 Renal endothelin system in polycystic kidney disease. J Am Soc Nephrol 9:1169-1177
23. Brunner F, Wolkart G 2001 Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronaryand peripheralvasodilation. Microvasc Res 61:102-110
24. Potter LR, Hunter T 2001 Guanylyl cyclase-linked natriuretic peptide receptors: structure and regulation. J Biol Chem 276:6057-6060
25. Hussain MB, Mac Allister RJ, Hobbs AJ 2001 Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases. Am J Physiol Heart Circ Physiol 280:H1151-H1159
26. Madhani M, Scotl and RS, Mac Allister RJ, Hobbs AJ 2003 Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Br JPharmacol 139:1289-1296
27. Delaey C, Boussery K, Breyne J, Vanheel B, Van de Voorde J 2007 The en- dothelium-derived hyperpolarising factor (EDHF) in isolated bovine choroidal arteries. Exp Eye Res 84:1067-1073
28. Mullershausen F, Friebe A, Feil R, Thompson WJ, Hofmann F, Koesling D 2003 Directactivation of PDE5 by cGMP: long-termeffects with in NO/cGMP signaling. J Cell Biol 160:719-727
29. Opgenorth TJ, Novosad EI 1990 Atrial natriuretic factor and endothelin interactions in control of vascular tone. Eur J Pharmacol 191:351-357
30. Matsukawa N, Grzesik WJ, Takahashi N, Pandey KN, Pang S, Yamauchi M, Smithies O 1999 The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA 96:7403-7408